Inflammasome and cardiovascular diseases;Rôle de l'inflammasome dans les pathologies cardiovasculaires

Annales de Cardiologie et d'Angeiologie

Volumn 60, Issue 1, 2011, Pages 48-54

  Connat, J L ^a  

^a UNIVERSITÉ DE BOURGOGNE   (France)

Author keywords

Atherosclerosis; Inflammasome; NALP; NLR; NLR mutations; NOD like receptor; Oxydative stress

Indexed keywords

CD11B ANTIGEN; CRYOPYRIN; INFLAMMASOME; INTERLEUKIN 18; INTERLEUKIN 1BETA; NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN LIKE RECEPTOR; OXIDIZED LOW DENSITY LIPOPROTEIN ANTIBODY;

ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; IMMUNOCYTOCHEMISTRY; MACROPHAGE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; SHORT SURVEY;

EID: 79951814029     PISSN: 00033928     EISSN: 17683181     Source Type: Journal    
DOI: 10.1016/j.ancard.2010.07.011     Document Type: Short Survey

References (61)

1. Martinon F., Burns K., Tschopp J. The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-β. Mol Cell 2002, 10:417-426.
2. Black R.A., Kronheim S.R., Merriam J.E., March C.J., Hopp T.P. A pre-aspartate-specific protease from human leukocytes that cleaves pro-interleukin-1 beta. J Biol Chem 1989, 264(10):5323-5326.
3. Kostura M.J., Tocci M.J., Limjuco G., Chin J., Cameron P., Hillman A.G., et al. Identification of a monocyte specific pre-interleukin 1 beta convertase activity. Proc Natl Acad Sci U S A 1989, 86(14):5227-5231.
4. Cerretti D.P., Kozlosky C.J., Mosley B., Nelson N., Van Ness K., Greenstreet T.A., et al. Molecular cloning of the interleukin-1 beta converting enzyme. Science 1992, 256(5053):97-100.
5. Thornberry N.A., Bull H.G., Calaycay J.R., Chapman K.T., Howard A.D., Kostura M.J., et al. A novel heterodimeric cysteine protease is required for interleukin-1 beta processing in monocytes. Nature 1992, 356(6372):768-774.
6. Mariathasan S. ASC, Ipaf and Cryopyrin/Nalp3: bona fide intracellular adapters of the caspase-1 inflammasome. Microbes Infect 2007, 9(5):664-671. [Review].
7. Mariathasan S., Monack D.M. Inflammasome adaptors and sensors: intracellular regulators of infection and inflammation. Nat Rev Immunol 2007, 7:31-40.
8. Martinon F., Tschopp J. Inflammatory caspases: linking an intracellular innate immune system to autoinflammatory diseases. Cell 2004, 117:561-574.
9. Pétrilli V., Papin S., Dostert C., Mayor A., Martinon F., Tschopp J. Activation of the NALP3 inflammasome is triggered by low intracellular potassium concentration. Cell Death Differ 2007, 14(9):1583-1589.
10. Sutterwala F.S., Mijares L.A., Li L., Ogura Y., Kazmierczak B.I., Flavell R.A. Immune recognition of Pseudomonas aeruginosa mediated by the IPAF/NLRC4 inflammasome. J Exp Med 2007, 204(13):3235-3245.
11. Ting J.P., Lovering R.C., Alnemri E.S., Bertin J., Boss J.M., Davis B.K., et al. The NLR gene family: a standard nomenclature. Immunity 2008, 28(3):285-287.
12. Kummer J.A., Broekhuizen R., Everett H., Agostini L., Kuijk L., Martinon F., et al. Inflammasome components NALP 1 and 3 show distinct but separate expression profiles in human tissues suggesting a site-specific role in the inflammatory response. J Histochem Cytochem 2007, 55(5):443-452.
13. Sutterwala F.S., Ogura Y., Zamboni D.S., Roy C.R., Flavell R.A. NALP3: a key player in caspase-1 activation. J Endotoxin Res 2006, 12(4):251-256.
14. Hoffman H.M., Mueller J.L., Broide D.H., Wanderer A.A., Kolodner R.D. Mutation of a new gene encoding a putative pyrin-like protein causes familial cold autoinflammatory syndrome and Muckle-Wells syndrome. Nat Genet 2001, 29(3):301-305.
15. Friedlander A.M. Macrophages are sensitive to anthrax lethal toxin through an acid-dependent process. J Biol Chem 1986, 261(16):7123-7126.
16. Boyden E.D., Dietrich W.F. Nalp1b controls mouse macrophage susceptibility to anthrax lethal toxin. Nat Genet 2006, 38(2):240-244.
17. Hysi P., Kabesch M., Moffatt M.F., Schedel M., Carr D., Zhang Y., et al. NOD1 variation, immunoglobulin E and asthma. Hum Mol Genet 2005, 14(7):935-941.
18. Ogura Y., Bonen D.K., Inohara N., Nicolae D.L., Chen F.F., Ramos R., et al. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature 2001, 411(6837):603-606.
19. Hugot J.P., Laurent-Puig P., Gower-Rousseau C., Olson J.M., Lee J.C., Beaugerie L., et al. Mapping of a susceptibility locus for Crohn's disease on chromosome 16. Nature 1996, 379(6568):821-823.
20. Kanazawa N., Okafuji I., Kambe N., Nishikomori R., Nakata-Hizume M., Nagai S., et al. Early-onset sarcoidosis and CARD15 mutations with constitutive nuclear factor-kappaB activation: common genetic etiology with Blau syndrome. Blood 2005, 105(3):1195-1197.
21. Jin Y., Mailloux C.M., Gowan K., Riccardi S.L., LaBerge G., Bennett D.C., et al. NALP1 in vitiligo-associated multiple autoimmune disease. N Engl J Med 2007, 356(12):1216-1225.
22. Agostini L., Martinon F., Burns K., McDermott M.F., Hawkins P.N., Tschopp J. NALP3 forms an IL-1beta-processing inflammasome with increased activity in Muckle-Wells autoinflammatory disorder. Immunity 2004, 20(3):319-325.
23. Watanabe H., Gaide O., Pétrilli V., Martinon F., Contassot E., Roques S., et al. Activation of the IL-1beta-processing inflammasome is involved in contact hypersensitivity. J Invest Dermatol 2007, 127(8):1956-1963.
24. Feldmeyer L., Keller M., Niklaus G., Hohl D., Werner S., Beer H.D. The inflammasome mediates UVB-induced activation and secretion of interleukin-1beta by keratinocytes. Curr Biol 2007, 17(13):1140-1145.
25. Roy N., Mahadevan M.S., McLean M., Shutler G., Yaraghi Z., Farahani R., et al. The gene for neuronal apoptosis inhibitory protein is partially deleted in individuals with spinal muscular atrophy. Cell 1995, 80(1):167-178.
26. Jéru I., Duquesnoy P., Fernandes-Alnemri T., Cochet E., Yu J.W., Lackmy-Port-Lis M., et al. Mutations in NALP12 cause hereditary periodic fever syndromes. Proc Natl Acad Sci U S A 2008, 105(5):1614-1619.
27. Kanneganti T.D., Body-Malapel M., Am A., Park J.H., Whitfield J., Franchi L., et al. Critical role for cryopyrin/Nalp3 in activation of caspase-1 in response to viral infection and double-stranded RNA. J Biol Chem 2006, 281:36560-36568.
28. Mariathasan S., Weiss D.S., Newton K., McBride J., O'Rourke K., Roose-Girma M., et al. Cryopyrin activates the inflammasome in response to toxins and ATP. Nature 2006, 440(7081):228-232.
29. Pétrilli V., Dostert C., Muruve D.A., Tschopp J. The inflammasome: a danger sensing complex triggering innate immunity. Curr Opin Immunol 2007, 19(6):615-622. [Review].
30. Gurcel L., Abrami L., Girardin S., Tschopp J., van der Goot F.G. Caspase-1 activation of lipid metabolic pathways in response to bacterial pore-forming toxins promotes cell survival. Cell 2006, 126:1135-1145.
31. Eisenbarth S.C., Colegio O.R., O'Connor W., Sutterwala F.S., Flavell R.A. Crucial role for the Nalp3 inflammasome in the immunostimulatory properties of aluminium adjuvants. Nature 2008, 453(7198):1122-1126.
32. Kool M., Pétrilli V., De Smedt T., Rolaz A., Hammad H., van Nimwegen M., et al. Cutting edge: alum adjuvant stimulates inflammatory dendritic cells through activation of the NALP3 inflammasome. J Immunol 2008, 181(6):3755-3759.
33. Hornung V., Bauernfeind F., Halle A., Samstad E.O., Kono H., Rock K.L., et al. Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization. Nat Immunol 2008, 9(8):847-856.
34. Cassel S.L., Eisenbarth S.C., Iyer S.S., Sadler J.J., Colegio O.R., Tephly L.A., et al. The Nalp3 inflammasome is essential for the development of silicosis. Proc Natl Acad Sci U S A 2008, 105(26):9035-9040.
35. Dostert C., Pétrilli V., Van Bruggen R., Steele C., Mossman B.T., Tschopp J. Innate immune activation through Nalp3 inflammasome sensing of asbestos and silica. Science 2008, 320(5876):674-677.
36. Shio M.T., Eisenbarth S.C., Savaria M., Vinet A.F., Bellemare M.J., Harder K.W., et al. Malarial hemozoin activates the NLRP3 inflammasome through Lyn and Syk kinases. PLoS Pathog 2009, 5(8):e1000559.
37. Martinon F., Pétrilli V., Mayor A., Tardivel A., Tschopp J. Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature 2006, 440:237-241.
38. Halle A., Hornung V., Petzold G.C., Stewart C.R., Monks B.G., Reinheckel T., et al. The NALP3 inflammasome is involved in the innate immune response to amyloid-beta. Nat Immunol 2008, 9(8):857-865.
39. Schroder K., Zhou R., Tschopp J. The NLRP3 inflammasome: a sensor for metabolic danger?. Science 2010, 327(5963):296-300. [Review].
40. Yang Y., Yin C., Pandey A., Abbott D., Sassetti C., Kelliher M.A. NOD2 pathway activation by MDP or Mycobacterium tuberculosis infection involves the stable polyubiquitination of Rip2. J Biol Chem 2007, 282(50):36223-36229.
41. Ogura Y., Inohara N., Benito A., Chen F.F., Yamaoka S., Nunez G. NOD2, a NOD1/Apaf-1 family member that is restricted to monocytes and activates NF-kappaB. J Biol Chem 2001, 276(7):4812-4818.
42. Dinarello C.A. Interleukin-1 beta, interleukin-18, and the interleukin-1 beta converting enzyme. Ann N Y Acad Sci 1998, 856:1-11. [Review].
43. Pan Q., Mathison J., Fearns C., Kravchenko V.V., Da Silva Correia J., Hoffman H.M., et al. MDP-induced interleukin-1beta processing requires NOD2 and CIAS1/NALP3. J Leukoc Biol 2007, 82(1):177-183.
44. Hsu L.C., Ali S.R., McGillivray S., Tseng P.H., Mariathasan S., Humke E.W., et al. A NOD2-NALP1 complex mediates caspase-1-dependent IL-1beta secretion in response to Bacillus anthracis infection and muramyl dipeptide. Proc Natl Acad Sci U S A 2008, 105(22):7803-7808.
45. Pedra J.H., Cassel S.L., Sutterwala F.S. Sensing pathogens and danger signals by the inflammasome. Curr Opin Immunol 2009, 21(1):10-16.
46. Barnich N., Aguirre J.E., Reinecker H.C., Xavier R., Podolsky D.K. Membrane recruitment of NOD2 in intestinal epithelial cells is essential for nuclear factor-{kappa}B activation in muramyl dipeptide recognition. J Cell Biol 2005, 170(1):21-26.
47. Billiet L, Rouis M. La thioredoxine-1: un nouvel acteur bénéfiqe dans plusieurs pathologies dont les maladies cardio- et cérébrovasculaires (2009). La Lettre de la NSFA, N (40 janvier 2009).
48. Zhou R., Tardivel A., Thorens B., Choi I., Tschopp J. Thioredoxin-interacting protein links oxidative stress to inflammasome activation. Nat Immunol 2010, (2):136-140.
49. Cartwright N., Murch O., McMaster S.K., Paul-Clark M.J., van Heel D.A., Ryffel B., et al. Selective NOD1 agonists cause shock and organ injury/dysfunction in vivo. Am J Respir Crit Care Med 2007, 175(6):595-603.
50. Kirii H., Niwa T., Yamada Y., Wada H., Saito K., Iwakura Y., et al. Lack of interleukin-1beta decreases the severity of atherosclerosis in ApoE-deficient mice. Arterioscler Thromb Vasc Biol 2003, 23(4):656-660.
51. Isoda K., Sawada S., Ishigami N., Matsuki T., Miyazaki K., Kusuhara M., et al. Lack of interleukin-1 receptor antagonist modulates plaque composition in apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol 2004, 24(6):1068-1073.
52. Merhi-Soussi F., Kwak B.R., Magne D., Chadjichristos C., Berti M., Pelli G., et al. Interleukin-1 plays a major role in vascular inflammation and atherosclerosis in male apolipoprotein E-knockout mice. Cardiovasc Res 2005, 66(3):583-593.
53. Elhage R., Jawien J., Rudling M., Ljunggren H.G., Takeda K., Akira S., et al. Reduced atherosclerosis in interleukin-18 deficient apolipoprotein E-knockout mice. Cardiovasc Res 2003, 59(1):234-240.
54. Whitman S.C., Ravisankar P., Daugherty A. Interleukin-18 enhances atherosclerosis in apolipoprotein E(-/-) mice through release of interferon-gamma. Circ Res 2002, 90(2):E34-E38.
55. Mallat Z., Corbaz A., Scoazec A., Graber P., Alouani S., Esposito B., et al. Interleukin-18/interleukin-18 binding protein signaling modulates atherosclerotic lesion development and stability. Circ Res 2001, 89(7):E41-E45.
56. Mallat Z., Besnard S., Duriez M., Deleuze V., Emmanuel F., Bureau M.F., et al. Protective role of interleukin-10 in atherosclerosis. Circ Res 1999, 85(8):e17-e24.
57. Taleb S., Romain M., Ramkhelawon B., Uyttenhove C., Pasterkamp G., Herbin O., et al. Loss of SOCS3 expression in T cells reveals a regulatory role for interleukin-17 in atherosclerosis. J Exp Med 2009, 206(10):2067-2077.
58. Yin Y., Yan Y., Jiang X., Mai J., Chen N.C., Wang H., et al. Inflammasomes are differentially expressed in cardiovascular and other tissues. Int J Immunopathol Pharmacol 2009, 22(2):311-322.
59. Pesant M, Giroux S, Hadi T, Rochette L, Connat JL. Expression of NALP3 (2008) inflammasome components NALP3, ASC and Caspase-1 in murine atherosclerosis: evidence for an oxLDL-induced stimulatory effect in macrophages. 77th Annual EAS Congress, 26-29 avril 2008, Istambul, Turquie.
60. Pesant M, Giroux S, Hadi T, Blache D, Rochette L, Connat JL (2007). Effet des LDL oxydées sur l'expression de marqueurs de l'inflammation dans les macrophages péritonéaux murins. 4e Congrès annuel de la NSFA, Biarritz.
61. Bernardini C, Gaibani P, Zannoni A, Vocale C, Bacci ML, Piana G, et al. Treponema denticola alters cell vitality and induces HO-1 and Hsp70 expression in porcine aortic endothelial cells. Cell Stress Chaperones 2009. [Epub ahead of print].